FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3112567194> ?p ?o ?g. }

• W3112567194 endingPage "1407" @default.
• W3112567194 startingPage "1400" @default.
• W3112567194 abstract "Given the mechanism of action of sodium-glucose cotransporter 2 inhibitors (SGLT2is), these drugs can also reduce bone density and increase fracture risk. We aimed to identify and characterize fracture-related adverse events that are associated with SGLT2is.In this observational, retrospective, pharmacovigilance, real-world study, we used disproportionality and Bayesian analyses to compare fracture-related adverse event reporting in patients who received SGLT2is from the first quarter in 2004 to the fourth quarter in 2019 in the Food and Drug Administration Adverse Event Reporting System. We also compared the effect on combined therapy with SGLT2is and other glucose-lowering medications (GLMs), and compared their onset times and outcomes.A total of 317 SGLT2is-associated fractures were identified. Affected patients tended to be aged >45 years (68.76%) and were more often male than female (58.04% vs 34.07%). SGLT2is-associated fracture is most commonly reported with canagliflozin (51.10%), dapagliflozin (24.60%) and empagliflozin (23.66%). SGLT2is or SGLT2is combined with GLMs do not show an association with fracture risk under disproportionality and Bayesian analyses. SGLT2i-associated fractures result in hospitalization in 66.64% of patients and death in 9.38% of patients. GLMs show an increased hospitalization rate compared with SGLT2is (69.72% vs 55.14%, P < 0.0001) and GLMs plus SGLT2is (69.72% vs 61.20%, P = 0.0197).Based on the Food and Drug Administration Adverse Event Reporting System database, no association is noted between fracture risk and SGLT2is, or SGLT2is combined with GLMs. Long-term follow up and high-quality studies need to further verify and explore the relationship between SGLT2is and fractures." @default.
• W3112567194 created "2020-12-21" @default.
• W3112567194 creator A5066294981 @default.
• W3112567194 creator A5069951259 @default.
• W3112567194 creator A5074761737 @default.
• W3112567194 creator A5085187324 @default.
• W3112567194 date "2021-01-17" @default.
• W3112567194 modified "2023-10-12" @default.
• W3112567194 title "Do sodium–glucose cotransporter 2 inhibitors lead to fracture risk? A pharmacovigilance real‐world study" @default.
• W3112567194 cites W1967555951 @default.
• W3112567194 cites W1971955840 @default.
• W3112567194 cites W1981809734 @default.
• W3112567194 cites W1988100739 @default.
• W3112567194 cites W2002810160 @default.
• W3112567194 cites W2009216796 @default.
• W3112567194 cites W2064716383 @default.
• W3112567194 cites W2142065502 @default.
• W3112567194 cites W2146264128 @default.
• W3112567194 cites W2147598330 @default.
• W3112567194 cites W2150959326 @default.
• W3112567194 cites W2173169652 @default.
• W3112567194 cites W2179831365 @default.
• W3112567194 cites W2607569327 @default.
• W3112567194 cites W2614137535 @default.
• W3112567194 cites W2626446274 @default.
• W3112567194 cites W2798054615 @default.
• W3112567194 cites W2805417982 @default.
• W3112567194 cites W2808317629 @default.
• W3112567194 cites W2808467887 @default.
• W3112567194 cites W2884267679 @default.
• W3112567194 cites W2884466498 @default.
• W3112567194 cites W2894993577 @default.
• W3112567194 cites W2895533920 @default.
• W3112567194 cites W2900413769 @default.
• W3112567194 cites W2902527999 @default.
• W3112567194 cites W2905078798 @default.
• W3112567194 cites W2925194642 @default.
• W3112567194 cites W2928289028 @default.
• W3112567194 cites W2939928664 @default.
• W3112567194 cites W2947802790 @default.
• W3112567194 cites W2953587006 @default.
• W3112567194 cites W2974260792 @default.
• W3112567194 cites W2977736009 @default.
• W3112567194 cites W2984886143 @default.
• W3112567194 cites W4237332786 @default.
• W3112567194 cites W4246340431 @default.
• W3112567194 cites W92486268 @default.
• W3112567194 doi "https://doi.org/10.1111/jdi.13481" @default.
• W3112567194 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8354498" @default.
• W3112567194 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33325646" @default.
• W3112567194 hasPublicationYear "2021" @default.
• W3112567194 type Work @default.
• W3112567194 sameAs 3112567194 @default.
• W3112567194 citedByCount "7" @default.
• W3112567194 countsByYear W31125671942021 @default.
• W3112567194 countsByYear W31125671942022 @default.
• W3112567194 countsByYear W31125671942023 @default.
• W3112567194 crossrefType "journal-article" @default.
• W3112567194 hasAuthorship W3112567194A5066294981 @default.
• W3112567194 hasAuthorship W3112567194A5069951259 @default.
• W3112567194 hasAuthorship W3112567194A5074761737 @default.
• W3112567194 hasAuthorship W3112567194A5085187324 @default.
• W3112567194 hasBestOaLocation W31125671941 @default.
• W3112567194 hasConcept C126322002 @default.
• W3112567194 hasConcept C134018914 @default.
• W3112567194 hasConcept C177713679 @default.
• W3112567194 hasConcept C197934379 @default.
• W3112567194 hasConcept C2775887513 @default.
• W3112567194 hasConcept C2777180221 @default.
• W3112567194 hasConcept C2777422806 @default.
• W3112567194 hasConcept C2777451236 @default.
• W3112567194 hasConcept C555293320 @default.
• W3112567194 hasConcept C57658597 @default.
• W3112567194 hasConcept C71924100 @default.
• W3112567194 hasConceptScore W3112567194C126322002 @default.
• W3112567194 hasConceptScore W3112567194C134018914 @default.
• W3112567194 hasConceptScore W3112567194C177713679 @default.
• W3112567194 hasConceptScore W3112567194C197934379 @default.
• W3112567194 hasConceptScore W3112567194C2775887513 @default.
• W3112567194 hasConceptScore W3112567194C2777180221 @default.
• W3112567194 hasConceptScore W3112567194C2777422806 @default.
• W3112567194 hasConceptScore W3112567194C2777451236 @default.
• W3112567194 hasConceptScore W3112567194C555293320 @default.
• W3112567194 hasConceptScore W3112567194C57658597 @default.
• W3112567194 hasConceptScore W3112567194C71924100 @default.
• W3112567194 hasIssue "8" @default.
• W3112567194 hasLocation W31125671941 @default.
• W3112567194 hasLocation W31125671942 @default.
• W3112567194 hasLocation W31125671943 @default.
• W3112567194 hasLocation W31125671944 @default.
• W3112567194 hasOpenAccess W3112567194 @default.
• W3112567194 hasPrimaryLocation W31125671941 @default.
• W3112567194 hasRelatedWork W2792565546 @default.
• W3112567194 hasRelatedWork W2923594802 @default.
• W3112567194 hasRelatedWork W2939048096 @default.
• W3112567194 hasRelatedWork W2983413169 @default.
• W3112567194 hasRelatedWork W2984644156 @default.
• W3112567194 hasRelatedWork W3029803913 @default.

• next